GIMD1: A Potential Drug Target and Biomarker (G100507096)
GIMD1: A Potential Drug Target and Biomarker
Glycopharmacutaneous intercellular adhesion molecule (GIMD1) is a protein that is expressed in various tissues and cells in the body. It is a member of the immunoglobulin superfamily and has been implicated in several cellular processes, including cell adhesion, migration, and invasion. GIMD1 has also been shown to play a role in the development and progression of several diseases, including cancer. As a result, GIMD1 has emerged as a potential drug target and biomarker for a variety of therapeutic applications.
GIMD1 has been shown to promote cell-cell adhesion and contribute to the development of tight junctions, which are critical for maintaining tissue structure and function. tight junctions are a type of cell-cell barrier that helps to prevent the movement of harmful substances and maintain the integrity of the intercellular space. In addition, GIMD1 has been shown to play a role in the regulation of cell migration and invasion. These functions are important for the development and progression of many diseases, including cancer.
GIMD1 has also been implicated in the regulation of inflammation and immune responses. It has been shown to interact with several immune molecules, including T cells, B cells, and natural killer cells. GIMD1 has also been shown to play a role in the regulation of inflammation-related processes, including the production of pro-inflammatory cytokines.
In addition to its role in cellular processes, GIMD1 has also been shown to play a role in the development and progression of several diseases. For example, GIMD1 has been implicated in the development of cancer, including breast cancer. It has also been shown to be involved in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.
GIMD1 has also been shown to have potential as a biomarker for several diseases. For example, GIMD1 has been used as a biomarker for cancer, with studies showing that higher levels of GIMD1 are associated with the development of cancer. In addition, GIMD1 has also been used as a biomarker for other diseases, such as autoimmune diseases and neurodegenerative diseases.
In conclusion, GIMD1 is a protein that has been shown to play a role in a variety of cellular processes and has been implicated in the development and progression of several diseases. As a result, GIMD1 has emerged as a potential drug target and biomarker for a variety of therapeutic applications. Further research is needed to fully understand the role of GIMD1 in these processes and to develop effective treatments for diseases associated with its dysfunction.
Protein Name: GIMAP Family P-loop NTPase Domain Containing 1
The "GIMD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GIMD1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GIN1 | GINM1 | GINS complex | GINS1 | GINS2 | GINS3 | GINS4 | GIP | GIPC1 | GIPC2 | GIPC3 | GIPR | GIT1 | GIT2 | GJA1 | GJA10 | GJA1P1 | GJA3 | GJA4 | GJA5 | GJA8 | GJA9 | GJA9-MYCBP | GJB1 | GJB2 | GJB3 | GJB4 | GJB5 | GJB6 | GJB7 | GJC1 | GJC2 | GJC3 | GJD2 | GJD3 | GJD4 | GK | GK2 | GK3 | GK5 | GKAP1 | GKN1 | GKN2 | GKN3P | GLA | GLB1 | GLB1L | GLB1L2 | GLB1L3 | GLC1C | GLCCI1 | GLCCI1-DT | GLCE | GLDC | GLDN | GLE1 | GLG1 | GLI1 | GLI2 | GLI3 | GLI4 | GLIDR | GLIPR1 | GLIPR1L1 | GLIPR1L2 | GLIPR2 | GLIS1 | GLIS2 | GLIS3 | GLIS3-AS1 | GLMN | GLMP | GLO1 | GLOD4 | GLOD5 | GLP1R | GLP2R | GLRA1 | GLRA2 | GLRA3 | GLRA4 | GLRB | GLRX | GLRX2 | GLRX3 | GLRX3P2 | GLRX5 | GLS | GLS2 | GLT1D1 | GLT6D1 | GLT8D1 | GLT8D2 | GLTP | GLTPD2 | Glucagon-like peptide receptor (GLP-R) | Glucosidase | GLUD1 | GLUD1P2 | GLUD1P3
